Role of natural bioactive compounds in the management of neurodegenerative disorders

Abstract

Lately, substantial exploration and study have focused on natural products, along with their bioactive compounds. Neurodegenerative diseases (NDDs) such as Alzheimer’s disease (AD), Huntington’s disease (HD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS) involve progressive neural breakdown and cell loss, culminating in neuronal death. The brain is susceptible to various forms of stress, particularly oxidative stress (OS) caused by the body’s oxygen requirements and utilization. The vulnerability of the brain is heightened by the significant presence of unsaturated fatty acids. To gain accurate insights into NDD, various factors such as genetics and environmental risks must be considered, as they can reduce the effectiveness of therapies for NDDs. Addressing oxidative damage and discovering safe and efficient treatments for NDDs are crucial objectives. In this pursuit, bioactive compounds play a vital role in research. Among these compounds, natural elements such as carotenoids, essential oils, essential fatty acids, polyphenols, and phytosterols are captivating due to their potent antioxidant and anti-inflammatory traits. These qualities hold the potential for enhancing brain health. This review centers on assessing how these bioactive compounds can bolster the brain’s limited antioxidant and regenerative abilities, foster neurogenesis, offer neuroprotection, and mitigate NDDs.

Keywords

Parkinson’s disease / Alzheimer’s disease / Neurodegeneration / Polyphenols / Neuroprotection

References

[1] Przedborski S, Vila M, Jackson-Lewis V. Series Introduction: neurodegeneration: what is it and where are we? J Clin Invest. 2003;111(1):3.

[2] Yildiz-Unal A, Korulu S, Karabay A. Neuroprotective strategies against calpainmediated neurodegeneration. Neuropsychiatric Dis Treat. 2015;11:297–310.

[3] Gao HM, Hong JS. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol. 2008;29(8):357–365.

[4] Babazadeh A, Vahed FM, Liu Q, et al. Natural bioactive molecules as neuromedicines for the treatment/prevention of neurodegenerative diseases. ACS Omega. 2022.

[5] Gorman AM. Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling: apoptosis Review Series. J Cell Mol Med. 2008;12(6A):2263–2280.

[6] Fan J, Dawson TM, Dawson VL. Cell death mechanisms of neurodegeneration. Adv Neurobiol. 2017;15:403–425.

[7] Glass CK, Saijo K, Winner B, et al. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140(6):918–934.

[8] Chen WW, Zhang X, Huang WJ. Role of neuroinflammation in neurodegenerative diseases. Mol Med Rep. 2016;13(4):3391–3396.

[9] Chitnis T, Weiner HL. CNS inflammation and neurodegeneration. J Clin Invest. 2017;127(10):3577–3587.

[10] Liu Z, Zhou T, Ziegler AC, et al. Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications. Oxid Med Cell Longev. 2017.

[11] Kamal M, Naz M, Jawaid T, Arif M. Natural products and their active principles used in the treatment of neurodegenerative diseases: a review. OPEM. 2019;19(4):343–365.

[12] Singh A, Kukreti R, Saso L, et al. Oxidative stress: a key modulator in neurodegenerative diseases. Molecules. 2019;24(8).

[13] Jellinger KA. General aspects of neurodegeneration. J Neural Transm Suppl. 2003;(65):101–144.

[14] Apostolova LG. Alzheimer disease. Continum Lifelong Learn Neurol Dementia. 2016;22(2):419–434.

[15] Allan Butterfield D, Boyd-Kimball D. Oxidative stress, amyloid-β peptide, and altered key molecular pathways in the pathogenesis and progression of alzheimer’s disease. J Alzheimers Dis. 2018;62(3):1345–1367.

[16] Loewen CA, Feany MB. The unfolded protein response protects from tau neurotoxicity in vivo. PLoS One. 2010;5(9):e13084.

[17] Albarracin SL, Stab B, Casas Z, et al. Effects of natural antioxidants in neurodegenerative disease. Nutr Neurosci. 2012;15(1):1–9.

[18] Cenini G, Lloret A, Cascella R. Oxidative stress in neurodegenerative diseases: from a mitochondrial point of view. Oxid Med Cell Longev. 2019.

[19] Prakash A, Kumar A. Implicating the role of lycopene in restoration of mitochondrial enzymes and BDNF levels in β-amyloid induced Alzheimer’s disease. Eur J Pharmacol. 2014;741:104–111.

[20] Postu PA, Sadiki FZ, El Idrissi M, et al. Pinus halepensis essential oil attenuates the toxic Alzheimer’s amyloid beta (1-42)-induced memory impairment and oxidative stress in the rat hippocampus. Biomed Pharmacother. 2019;112:108673.

[21] Mhyre TR, Boyd JT, Hamill RW, et al. Parkinson’s disease. Subcell Biochem. 2012;65:389–455.

[22] Emamzadeh FN, Surguchov A. Parkinson’s disease: biomarkers, treatment, and risk factors. Front Neurosci. 2018;12.

[23] Leigh PN, Abrahams S, Al-Chalabi A, et al. The management of motor neuron disease. J Neurol Neurosurg Psychiatry. 2003;74(4):32–47.

[24] Hsu YT, Chang YG, Chern Y. Insights into GABAAergic system alteration in Huntington’s disease. Open Biol. 2018;8:12.

[25] Manzo E, O’Conner AG, Barrows JM, et al. Medium-chain fatty acids, beta-hydroxybutyric acid and genetic modulation of the carnitine shuttle are protective in a Drosophila model of ALS based on TDP-43. Front Mol Neurosci. 2018;11.

[26] Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942–955.

[27] Arif M, Fareed S, Hussain T, Ali M. Adaptogenic activity of lanostane triterpenoid isolated from Carissa carandas fruit against physically and chemically challenged experimental mice. Pharmacogenomics J. 2013;5:216–220.

[28] Arif M, Fareed S, Rahman Md A. Stress relaxant and antioxidant activities of acid glycoside from Spondias mangifera fruit against physically and chemically challenged albino mice. J Pharm Bioallied Sci. 2016;8:58–63.

[29] MacDonald ME, Ambrose CM, Duyao MP, et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. The Huntington’s Disease Collaborative Research Group. Cell. 1993;72(6):971–983.

[30] Reddy PH, Shirendeb UP. Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington’s disease. Biochim Biophys Acta. 2012;1822(2):101–110.

[31] Lalotra S, Vaghela JS. Scientific reports of medicinal plants used for the prevention and treatment of neurodegenerative diseases. Pharma Biosci J. 2019:15–25.

[32] Faridi Esfanjani A, Jafari SM. Biopolymer nano-particles and natural nano-carriers for nano-encapsulation of phenolic compounds. Colloids Surf B Biointerfaces. 2016;146:532–543.

[33] Assadpour E, Jafari SM, Esfanjani AF. Protection of phenolic compounds within nanocarriers. CAB Rev: Perspect Agric Vet Sci Nutr Nat Resour. 2017;12:1–8.

[34] Rao AV, Balachandran B. Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr Neurosci. 2002;5(5):291–309.

[35] Khan AB, Bhuvaneshwari J, Arif M. Microwave supported extraction and optimization of flavonoid mangiferin from mangifera indica L. Stem bark using orthogonal array design. RJPT. 2023;16(3):1113–1117.

[36] Kumar S, Arif M, Kamal M, Jawaid T, et al. Ex vivo antiplatelet and thrombolytic activity of bioactive fractions from the new-fangled stem buds of Ficus religiosa L. With simultaneous GC-MS examination. Molecules. 2023;28:3918.

[37] Singh P, Arif M, Shafi S, et al. In vitro and ex vivo studies to assess the antiurolithiasis activity of phenolic components of Ricinus communis L. and Euphorbia hirta L. with simultaneous HPTLC analysis. Ann Phytomed. 2022;11(1):1–8.

[38] Nury T, Yammine A, Ghzaiel I, et al. Attenuation of 7-ketocholesterol-and 7β-hydroxycholesterol-induced oxiapoptophagy by nutrients, synthetic molecules and oils: potential for the prevention of age-related diseases. Ageing Res Rev. 2021;68.

[39] Usmani S, Shoebuddin S, Hussain A, Wahab S, et al. Antioxidant potential of crude extract, flavonoid-rich fractions, and a new compound from the seeds of Cordia dichotoma. IJNPR. 2021;12:437–444.

[40] Gao Y, Hong YL, Yin LC, et al. Ultrafast growth of high-quality monolayer WSe2 on Au. Adv Math. 2017;29(29):1700990.

[41] Kim E, Lee J, Kim D, et al. Solvent-responsive polymernanocapsules with controlled permeability: encapsulation and release of a fluorescent dye by swelling and deswelling. Chem Commun (J Chem Soc Sect D). 2009;(12):1472–1474.

[42] Jiang F, DeSilva S, Turnbull J. Beneficial effect of ginseng root in SOD-1 (G93A) transgenic mice. J Neurol Sci. 2000;180(1–2):52–54.

[43] Kumar S, Arif M, Jawaid T, et al. Antiplatelet and thrombolytic activity of phenolic-insistent fractions from the new-fangled stem of Ficus benghalensis with concurrent GC-MS analysis. Intell Pharm. 2023 Jul 31.

[44] Piao M, Mori D, Satoh T, et al. Inhibition of endothelial cell proliferation, in vitro angiogenesis, and the down-regulation of cell adhesion-related genes by genistein. Combined with a cDNA microarray analysis. Endothelium. 2006;13(4):249–266.

[45] Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5(6):493–506.

[46] Han S, Choi JR, Soon Shin K, et al. Resveratrol upregulated heat shock proteins and extended the survival of G93A-SOD1 mice. Brain Res. 2012;1483:112–117.

[47] Ajiboye BO, Ojo OA, Okesola MA, et al. In vitro antioxidant activities and inhibitory effects of phenolic extract of Senecio biafrae (Oliv and Hiern) against key enzymes linked with type II diabetes mellitus and Alzheimer’s disease. Food Sci Nutr. 2018;6(7):1803.

[48] Bahadori MB, Salehi P, Sonboli A. Comparative study of the essential oil composition of Salvia urmiensis and its enzyme inhibitory activities linked to diabetes mellitus and Alzheimer’s disease. Int J Food Prop. 2017;20(12):2974–2981.

[49] Abdulqadir A, Cakmak YS, Zengin G. Phenolic compounds, antioxidant properties and enzyme inhibition ability of Adiantum capillus veneris L. Linked to alzheimer’s disease, diabetes mellitus and skin disorders. Curr Org Chem. 2018;22(17):1697–1703.

[50] Wang D, Ho L, Faith J, et al. Role of intestinal microbiota in the generation of polyphenol-derived phenolic acid mediated attenuation of Alzheimer’s disease β-amyloid oligomerization. Mol Nutr Food Res. 2015;59(6):1025–1040.

[51] Custódio L, Patarra J, Alberício F, et al. Phenolic composition, antioxidant potential and in vitro inhibitory activity of leaves and acorns of Quercus suber on key enzymes relevant for hyperglycemia and Alzheimer’s disease. Ind Crops Prod. 2015;64:45–51.

[52] Rose KN, Barlock BJ, DaSilva NA, et al. Anti-neuroinflammatory effects of a food-grade phenolic-enriched maple syrup extract in a mouse model of Alzheimer’s disease, ???Nutr Neurosci, 24(9):710–719.

[53] wei Wang S, gao Yang S, Liu W, et al. Alpha-tocopherol quinine ameliorates spatial memory deficits by reducing beta-amyloid oligomers, neuroinflammation and oxidative stress in transgenic mice with Alzheimer’s disease. Behav Brain Res. 2016;296:109–117.

[54] Sugimoto K, Tamura K, Ohta N, et al. Synthesis of dihydrofuran-fused perhydrophenanthrenes having a phenolic hydroxyl group as a novel anti-Alzheimer’s disease agent. Bioorg Med Chem Lett. 2012;22(1):449–452.

[55] Cole GM, Lim GP, Yang F, et al. Prevention of Alzheimer’s disease: Omega-3 fatty acid and phenolic anti-oxidant interventions. Neurobiol Aging. 2005;26(1):133–136.

[56] Rehman A, Tong Q, Jafari SM, et al. Carotenoid-loaded nanocarriers: a comprehensive review. Adv Colloid Interface Sci. 2020:275.

[57] Hussain MS, Azam F, Eldarrat HA, Haque A, Khalid M, et al. Structural, functional, molecular, and biological evaluation of novel triterpenoids isolated from Helichrysum stoechas (L.) Moench. collected from Mediterranean Sea bank: misurata-Libya. Arab J Chem. 2022:103818.

[58] Alyahya S, Arif M, Wasim R, Kushwaha SP. Phoenix dactylifera L. (Ajwa Dates): an energetic plant fruit with immense nutraceutical value for strengthening the power of resistance. J Pharmacogn Phytochem. 2022;11(3):151–162.

[59] Prema A, Janakiraman U, Manivasagam T, et al. Neuroprotective effect of lycopene against MPTP induced experimental Parkinson’s disease in mice. Neurosci Lett. 2015;599:12–19.

[60] Kaur H, Chauhan S, Sandhir R. Protective effect of lycopene on oxidative stress and cognitive decline in rotenone-induced model of Parkinson’s disease. Neurochem Res. 2011;36(8):1435–1443.

[61] Kiko T, Nakagawa K, Tsuduki T, et al. Significance of lutein in red blood cells of alzheimer’s disease patients. J Alzheim Dis. 2012;28(3):593–600.

[62] Nolan JM, Mulcahy R, Power R, et al. Nutritional intervention to prevent alzheimer’s disease: potential benefits of xanthophyll carotenoids and Omega-3 fatty acids combined. J Alzheim Dis. 2018;64(2):367–378.

[63] Hira S, Saleem U, Anwar F, et al. β-Carotene: a natural compound improves cognitive impairment and Oxidative stress in a mouse model of streptozotocininduced alzheimer’s disease. Biomolecules. 2019;9:441.

[64] Geeta M, Virmani T, Arif M. Implementation Of box behnken design to fabricate the formulation, optimization and dissolution Of blueberry nanosuspension. J Pharm Negat Results. 2022:595–605.

[65] Chen W, Mao L, Xing H, et al. Lycopene attenuates Aβ1–42 secretion and its toxicity in human cell and Caenorhabditis elegans models of Alzheimer disease. Neurosci Lett. 2015;608:28–33.

[66] Sachdeva AK, Chopra K. Lycopene abrogates Aβ(1-42)-mediated neuroinflammatory cascade in an experimental model of Alzheimer’s disease. J Nutr Biochem. 2015;26(7):736–744.

[67] Jain D, Gangshettiwar A. Combination of lycopene, quercetin and poloxamer 188 alleviates anxiety and depression in 3-nitropropionic acid-induced Huntington’s disease in rats. J Intercult Ethnopharmacol. 2014;3(4):186.

[68] Imran M, Imran M, Khan S, Arif M. Evaluation of antimicrobial properties of some Indian medicinal plants against MDR pathogenic bacteria. Int J Res Pharm Sci. 2017;8(4):522–533.

[69] Bahrami A, Delshadi R, Assadpour E, et al. Antimicrobial-loaded nanocarriers for food packaging applications. Adv Colloid Interface Sci. 2020:278.

[70] Abuhamdah S, Abuhamdah R, Howes MJR, et al. Pharmacological and neuroprotective profile of an essential oil derived from leaves of Aloysia citrodora Palau. J Pharm Pharmacol. 2015;67(9):1306–1315.

[71] Beserra-Filho JIA, de Macêdo AM, Leão AHFF, et al. Eplingiella fruticosa leaf essential oil complexed with β-cyclodextrin produces a superior neuroprotective and behavioral profile in a mice model of Parkinson’s disease. Food Chem Toxicol. 2019;124:17–29.

[72] Eram S, Mujahid M, Bagga P, Arif M, et al. A review on phytopharmacological activity of Alpinia galanga. Int J Pharm Pharmaceut Sci. 2019;13(3):6–11.

[73] Khan A, Badruddeen, Mishra A, et al. Cognition enhancing and antioxidant activities of Nepeta hindostana. (Roth) Haines flowers extract against scopolamineinduced amnesia in Sprague Dawley rats” YMER. 2023;22(5):1212–1226.

[74] Satou T, Hanashima Y, Mizutani I, et al. The effect of inhalation of essential oil from Rosmarinus officinalis on scopolamine-induced Alzheimer’s type dementia model mice. Flavour Fragrance J. 2018;33(3):230–234.

[75] Ali-Shtayeh MS, Jamous RM, Abu-Zaitoun SY, et al. Biological properties and bioactive components of Mentha spicata L. Essential Oil: focus on potential benefits in the treatment of obesity, alzheimer’s disease. In: Dermatophytosis, and Drug-Resistant Infections. Evid based Complem and Alt Med;2019.

[76] Sadiki FZ, Idrissi M El, Cioanca O, et al. Tetraclinis articulata essential oil mitigates cognitive deficits and brain oxidative stress in an Alzheimer’s disease amyloidosis model. Phytomedicine. 2019;56:57–63.76a. Chen S, Du X, Wang T, et al. Synthesis of near-infrared responsive gold nanoroddoped gelatin/hydroxyapatite composite microspheres with controlled photothermal property. Ceram Int. 2018a;44(1):900–904.

[77] Zhu S, Li H, Dong J, et al. Rose essential Oil delayed alzheimer’s disease-like symptoms by SKN-1 pathway in C. elegans. J Agric Food Chem. 2017;65(40):8855–8865.

[78] Shamim A, Kumar A, Mahmood T, et al. Lipids: an insight into the neurodegenerative disorders. Clin Nutr Exp. 2018;20:1–19.

[79] Kumar A, Hussain S, Singh K, et al. Phytochemical and biological studies of Solanum torvum L. in folklore medicine of Assam”. Ann Phytomed. 2023;12(1):1–8.

[80] Bahadori MB, Salehi P, Sonboli A. Comparative study of the essential oil composition of Salvia urmiensis and its enzyme inhibitory activities linked to diabetes mellitus and. Alzheimer’s Dementia. 2017;20(12):2974–2981.

[81] Bourre JM. Omega-3 fatty acids in psychiatry. M-S (Med Sci). 2005;21(2):216–221.

[82] Igarashi M, Ma K, Chang L, et al. Dietary n-3 PUFA deprivation for 15 weeks upregulates elongase and desaturase expression in rat liver but not brain. J Lipid Res. 2007.

[83] Arsenault D, Julien C, Chen CT, et al. Dietary intake of unsaturated fatty acids modulates physiological properties of entorhinal cortex neurons in mice. J Neurochem. 2012;122(2):427–443.

[84] Bousquet M, Calon F, Cicchetti F. Impact of ω-3 fatty acids in Parkinson’s disease. Ageing Res Rev. 2011;10(4):453–463.

[85] Lin YH, Lin SF, Chi YC, et al. Using n-and p-Type Bi₂Te₃ topological insulator nanoparticles to enable controlled femtosecond mode-locking of fiber lasers. ACS Photonics. 2015;2(4):481–490.

[86] Mori MA, Delattre AM, Carabelli B, et al. Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson’s disease is mediated by a reduction of inducible nitric oxide synthase. Nutr Neurosci. 2018;21(5):341–351.

[87] Diaper DC, Adachi Y, Sutcliffe B, et al. Loss and gain of Drosophila TDP-43 impair synaptic efficacy and motor control leading to age-related neurodegeneration by loss-of-function phenotypes. Hum Mol Genet. 2013;15(8):1539–1557, 22.

[88] Wang L, Fan H, He J, et al. Protective effects of omega-3 fatty acids against Alzheimer’s disease in rat brain endothelial cells. Brain Behav. 2018;8(11):e01037.

[89] Furman R, Axelsen PH. The effects of omega-3 fatty acid deficiency during development on oxidative fatty acid degradation during maturity in a mouse model of Alzheimer’s disease. Neurobiol Aging. 2019;79:66–74.

[90] Fang G, Shi B, Wu K, Chen S, et al. The protective role of endogenous n-3 polyunsaturated fatty acids in Tau Alzheimer’s disease mouse model. Int J Neurosci. 2019;129(4):325–336, 3.

[91] Raefsky SM, Furman R, Milne G, et al. Deuterated polyunsaturated fatty acids reduce brain lipid peroxidation and hippocampal amyloid β-peptide levels, without discernible behavioral effects in an APP/PS1 mutant transgenic mouse model of Alzheimer’s disease. Neurobiol Aging. 2018;66:165–176.

[92] Qadir A, Ali A, Arif M, et al. Solvent extraction and GC-MS analysis of sesame seeds for determination of bioactive antioxidant fatty acid/fatty oil components. Drug Research. 2018;68(6):344–348.

[93] Das UN, Vaddadi KS. Essential fatty acids in Huntington’s disease. Nutrition. 2004;20(10):942–947.

[94] Alfei S, Schito AM, Zuccari G. Nanotechnological manipulation of nutraceuticals and phytochemicals for healthy purposes: established advantages vs. still undefined risks. Polymers. 2021;13(14):2262.

[95] Ansari VA, Arif M, Siddiqui HH, Dixit RK. Antiplatelet activity and isolation of triterpenoidal glycoside from ethanolic extract of Nepeta hindostana. OPEM. 2016;16:333–337.

[96] Mohammadi M, Jafari SM, Hamishehkar H, et al. Phytosterols as the core or stabilizing agent in different nanocarriers. Trends Food Sci Technol. 2020;101:73–88.

[97] Madigan JB, Wilcock DM, Hainsworth AH. Vascular contributions to cognitive impairment and dementia: topical review of animal models. Stroke. 2016;47(7):1953–1959.

[98] Párraga-Martínez I, López-Torres-Hidalgo JD, del Campo-del Campo JM, et al. Long-term effects of plant stanols on the lipid profile of patients with hypercholesterolemia. A randomized clinical trial. Rev Esp Cardiol. 2015;68(8):665–671.

[99] Zahid M, Mujahid M, Singh PK, et al. Annona squamosa linn. (Custard apple): an aromatic medicinal plant fruit with immense nutraceutical and therapeutic potentials. IJPSR. 2018;9(5):1745–1759.

[100] Vanmierlo T, Rutten K, van Vark -van der Zee LC, et al. Cerebral accumulation of dietary derivable plant sterols does not interfere with memory and anxiety related behavior in Abcg5-/-mice. Plant Foods Hum Nutr. 2011;66(2):149–156.

[101] Arif M, Kamal M, Jawaid T, Khalid M, et al. Carissa carandas Linn. (Karonda): an exotic minor plant fruit with immense value in nutraceutical and pharmaceutical industries. Asian J Biomed Pharma Sci. 2016;6(58):14–19.

[102] Koivisto H, Grimm MO, Rothhaar TL, et al. Special lipid-based diets alleviate cognitive deficits in the APPswe/PS1de9 transgenic mouse model of Alzheimer’s disease independent of brain amyloid deposition. J Nutr Biochem. 2014;25(2):157–169.

[103] Hussain MS, Azam F, Mezogi J, et al. A simple validated HPTLC method for the analysis of flavonoids and molecular docking studies of novel tri-terpenoid glycoside isolated from Carya illinoinensis bark with potential anti-inflammatory and antinociceptive activities. South Afr J Bot. 2022;147:596–607.

[104] Katouzian I, Jafari SM. Nano-encapsulation as a promising approach for targeted delivery and controlled release of vitamins. Trends Food Sci Technol. 2016;53:34–48.

[105] Hacquebard M, Carpentier YA. Vitamin E: absorption, plasma transport and cell uptake. Curr Opin Clin Nutr Metab Care. 2005;8(2):133–138.

[106] Gugliandolo A, Chiricosta L, Silvestro S, et al. α-Tocopherol modulates non-amyloidogenic pathway and autophagy in an in vitro model of alzheimer’s disease: a transcriptional study. Brain Sci. 2019;9:196, 2019;9(8):196.

[107] Elfakhri KH, Abdallah IM, Brannen AD, et al. Multi-faceted therapeutic strategy for treatment of Alzheimer’s disease by concurrent administration of etodolac and α-tocopherol. Neurobiol Dis. 2019;125:123–134.

[108] Figueiredo CP, Bicca MA, Latini A, et al. Folic acid plus α-tocopherol mitigates amyloid-β-induced neurotoxicity through modulation of mitochondrial complexes activity. J Alzheim Dis. 2011;24(1):61–75.

[109] Morris MC, Evans DA, Tangney CC, et al. Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am J Clin Nutr. 2005;81(2):508–514.

[110] Ojea-Jiménez I, Bastús NG, Puntes V. Influence of the sequence of the reagents addition in the citrate-mediated synthesis of gold nanoparticles. J Phys Chem C. 2011;115(32):15752–15757.

[111] Takeda A, Nyssen OP, Syed A, et al. Vitamin A and carotenoids and the risk of Parkinson’s disease: a systematic review and meta-analysis. Neuroepidemiology. 2013;42(1):25–38.

RIGHTS & PERMISSIONS

2023 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.